Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00269620 · ClinicalTrials.gov registry record · Phase 4
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
NCT00269620 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 500 participants.
The verdict
NCT00269620, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
Study Summary
This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four months. Women must either be on the pill or have recently stopped the pill and be relatively satisfied with oral contraceptive use to qualify for enrollment. Two visits and two phone calls will be required.
Interventions
- DRUG ethinyl estradiol/etonogestrel vaginal ring
- DRUG ethinyl estradiol/norelgestromin transdermal contraceptive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00269620
The ClinicalTrials.gov registry entry for NCT00269620 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ethinyl estradiol/etonogestrel vaginal ring is the first listed.
NCT00269620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00269620 about?
NCT00269620 is a clinical study titled "PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra". This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four ...
What is the current status of trial NCT00269620?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2005-06. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00269620?
The interventions under investigation include: ethinyl estradiol/etonogestrel vaginal ring (DRUG), ethinyl estradiol/norelgestromin transdermal contraceptive (DRUG).
Who is sponsoring clinical trial NCT00269620?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.